PVLA
Palvella Therapeutics
PVLA
PVLA
115 hedge funds and large institutions have $232M invested in Palvella Therapeutics in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 54 increasing their positions, 11 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
0.13% more ownership
Funds ownership: 0.66% → 0.79% (+0.13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
75% less call options, than puts
Call options by funds: $244K | Put options by funds: $973K
Holders
115
Holding in Top 10
1
Calls
$244K
Puts
$973K
Top Buyers
| 1 | +$9.17M | |
| 2 | +$7.67M | |
| 3 | +$6.61M | |
| 4 |
Renaissance Technologies
New York
|
+$6M |
| 5 |
Morgan Stanley
New York
|
+$5.01M |
Top Sellers
| 1 | -$11.7M | |
| 2 | -$1.1M | |
| 3 | -$1.09M | |
| 4 |
OFM
Omega Fund Management
Boston,
Massachusetts
|
-$858K |
| 5 |
Two Sigma Investments
New York
|
-$734K |